COVID-19 in congenital heart disease (COaCHeD) study
Authors:
Open Access
- 17 July 2023
- journal article
- research article
- Published by BMJ in Open Heart
- Vol. 10 (2) , e002356
Abstract
Background COVID-19 has caused significant worldwide morbidity and mortality. Congenital heart disease (CHD) is likely to increase vulnerability and understanding the predictors of adverse outcomes is key to optimising care. Objective Ascertain the impact of COVID-19 on people with CHD and define risk factors for adverse outcomes. Methods Multicentre UK study undertaken 1 March 2020–30 June 2021 during the COVID-19 pandemic. Data were collected on CHD diagnoses, clinical presentation and outcomes. Multivariable logistic regression with multiple imputation was performed to explore predictors of death and hospitalisation. Results There were 405 reported cases (127 paediatric/278 adult). In children (age Conclusions Children were at low risk of death and hospitalisation secondary to COVID-19 even with severe CHD, but hospital admission rates were higher in younger children, independent of comorbidity. In adults, higher likelihood of death was associated with increasing age and PAH, and of hospitalisation with age, comorbidities and genetic disease. An individualised approach, based on age and comorbidities, should be taken to COVID-19 management in patients with CHD.Keywords
Funding Information
- British Congenital Cardiac Association (Funded open access costs for publication)
This publication has 13 references indexed in Scilit:
- COVID-19 in Adults With Congenital Heart DiseaseJACC, 2021
- Clinical outcome of COVID-19 in patients with adult congenital heart diseaseHeart, 2021
- Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and DeathsAnnals of Internal Medicine, 2021
- Impact of COVID-19 on patients with congenital heart diseaseCardiology in the Young, 2020
- Impact of Coronavirus Disease 2019 (COVID‐19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York CityJournal of the American Heart Association, 2020
- SARS-CoV-2 Infection in Patients with Down Syndrome, Congenital Heart Disease, and Pulmonary Hypertension: Is Down Syndrome a Risk Factor?The Journal of Pediatrics, 2020
- Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational studyThe Lancet Child & Adolescent Health, 2020
- Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric HospitalPediatric Cardiology, 2020
- COVID-19 and Congenital Heart Disease: Results from a Nationwide SurveyJournal of Clinical Medicine, 2020
- Adjusted indices of multiple deprivation to enable comparisons within and between constituent countries of the UK including an illustration using mortality ratesBMJ Open, 2016